CSIMarket
 


Apexigen Inc   (APGN)
Other Ticker:  
 
 

APGN's Income from Cont. Operations Growth by Quarter and Year

Apexigen Inc 's Income from Cont. Operations results by quarter and year




APGN Income from Cont. Operations (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -19.45 -0.11 0.00
III Quarter September - -8.49 0.08 0.00
II Quarter June -6.05 -1.67 -0.28 0.00
I Quarter March -6.05 -2.46 -0.17 0.00
FY   -12.10 -32.07 -0.48 0.00



APGN Income from Cont. Operations second quarter 2023 Y/Y Growth Comment
Apexigen Inc in the second quarter 2023 recorded loss from continued operations of $ -6.05 millions.

According to the results reported in the second quarter 2023, Apexigen Inc achieved the best Income from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Apexigen Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. in the second quarter 2023.




APGN Income from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Apexigen Inc 's second quarter 2023 Income from Cont. Operations $ -6.05 millions APGN's Income Statement
Apexigen Inc 's second quarter 2022 Income from Cont. Operations $ -1.67 millions Quarterly APGN's Income Statement
New: More APGN's historic Income from Cont. Operations Growth >>


APGN Income from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Apexigen Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


APGN's II. Quarter Q/Q Income from Cont. Operations Comment
II. Quarter 2023 results of -6.05 millions by Apexigen Inc look even less good if you take a look at -6.05 millions loss from continued operations in the previous quarter.

Within Major Pharmaceutical Preparations industry Apexigen Inc achieved highest sequential Income from Cont. Operations growth. While Apexigen Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


APGN's II. Quarter Q/Q Income from Cont. Operations Comment
Recent results of -6.05 millions by Apexigen Inc come out even less good compare to the loss from continued operations -6.05 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Apexigen Inc achieved highest sequential Income from Cont. Operations growth. While Apexigen Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Apexigen Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Income from Cont. Operations 12 Months Ending $ -40.04 $ -35.66 $ -32.07 $ -12.73 $ -4.16
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
Apexigen Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -40 millions in the Jun 30 2023 period.
The situation is getting worse as the cumulative loss from continued operations is becoming larger from $ -35.66 millions in TTM ending quarter Mar 31 2023 and $ -2.771721 millions for the twelve months ending in the quarter Jun 30 2022 Janu Lopes mentioned.

Apexigen Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
Apexigen Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -40 millions in the Jun 30 2023 period.
The situation is getting worse as the cumulative loss from continued operations is getting bigger from $ -35.66 millions in the twelve months ending a quarter before and $ -2.771721 millions for the twelve months ending in the quarter Jun 30 2022.

Apexigen Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
APGN's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for APGN's Competitors
Income from Cont. Operations Growth for Apexigen Inc 's Suppliers
Income from Cont. Operations Growth for APGN's Customers

You may also want to know
APGN's Annual Growth Rates APGN's Profitability Ratios APGN's Asset Turnover Ratio APGN's Dividend Growth
APGN's Roe APGN's Valuation Ratios APGN's Financial Strength Ratios APGN's Dividend Payout Ratio
APGN's Roa APGN's Inventory Turnover Ratio APGN's Growth Rates APGN's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Jun 30 2023
Surgery Partners Inc 277.12%$ 277.124 millions
Elite Pharmaceuticals Inc 273.28%$ 273.283 millions
Option Care Health Inc 237.18%$ 237.184 millions
Halozyme Therapeutics Inc 229.53%$ 229.531 millions
Airsculpt Technologies Inc 204.63%$ 204.631 millions
Jazz Pharmaceuticals Plc201.28%$ 201.278 millions
Synaptogenix Inc 183.43%$ 183.432 millions
Nature s Sunshine Products inc 181.20%$ 181.197 millions
Adhera Therapeutics Inc 173.74%$ 173.737 millions
Electromed Inc 169.71%$ 169.713 millions
Cadre Holdings Inc 147.29%$ 147.289 millions
Viemed Healthcare Inc 140.95%$ 140.951 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com